Indication

Prevention of skeletal related events in multiple myeloma

Multiple myeloma is a hematologic malignancy characterized by the clonal proliferation of abnormal plasma cells within the bone marrow. Read more about Prevention of skeletal related events in multiple myeloma

51 drugs 42 manufacturers

Advertisement

Drugs that treat it

Common Prevention of skeletal related events in multiple myeloma therapies.

Showing 10–18 of 51 drugs

ZOLEDRONIC ACID

HYPERCALCEMIA AGENTS·HUMORAL HYPERCALCEMIA OF MALIGNANCY·+2
SAGENT PHARMACE

ZOLEDRONIC ACID

HYPERCALCEMIA AGENTS·HUMORAL HYPERCALCEMIA OF MALIGNANCY·+2
SUN PHARMA GLOB

ZOLEDRONIC ACID

HYPERCALCEMIA AGENTS·HUMORAL HYPERCALCEMIA OF MALIGNANCY·+2
DR.REDDY'S LAB
Filter & compare in the drug finder →Opens the drug finder with Prevention of skeletal related events in multiple myeloma preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Prevention of skeletal related events in multiple myeloma.

Multiple myeloma is a hematologic malignancy characterized by the clonal proliferation of abnormal plasma cells within the bone marrow.

Malignant plasma cells disrupt normal bone remodeling by stimulating osteoclast-mediated bone resorption—frequently via upregulation of receptor activator of nuclear factor-?B ligand (RANKL)—while simultaneously suppressing osteoblastic bone formation.

This imbalance leads to progressive bone destruction, osteolytic lesions, and severe generalized bone loss throughout the skeletal system.

Prevention of skeletal-related events focuses on averting debilitating structural complications of this disease process, specifically pathologic fractures, spinal cord compression, and the necessity for radiation therapy or orthopedic surgery to manage compromised bone.

Personalize your experience

Follow Prevention of skeletal related events in multiple myeloma and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it